Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model

Colistin, administered as its inactive prodrug colistin methanesulfonate (CMS), is often used in multidrug-resistant Gram-negative pulmonary infections. The CMS and colistin pharmacokinetics in plasma and epithelial lining fluid (ELF) following intravenous and pulmonary dosing have not been evaluate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Landersdorfer, Cornelia B., Nguyen, Tri-Hung, Lieu, Linh Thuy, Nguyen, Gary, Bischof, Robert J., Meeusen, Els N., Li, Jian, Nation, Roger L., McIntosh, Michelle P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192148/
https://ncbi.nlm.nih.gov/pubmed/27821445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01934-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados